InvestorsHub Logo
Followers 0
Posts 167
Boards Moderated 0
Alias Born 08/28/2016

Re: learning curve post# 10168

Thursday, 01/19/2017 11:51:31 PM

Thursday, January 19, 2017 11:51:31 PM

Post# of 43830
It's not that CVM can't reply to what the FDA is asking for.

Inventiv's past performance is directly related to the adjustment of the trial, CVM blames Inventiv for the losses and expenses they suffered due to their performance.

The FDA places the trial on partial hold due to the adjustment initiated by CVM which to a certain extent is related to Inventiv's performance.

The FDA requests from CVM a full response but CVM provides a full response with limitations that are due to Inventiv's performance.

CVM is a victim.

Who is to blame?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News